Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
Key Highlights
- ➤200-liter Entolimod run completed with approximately 27% higher productivity
- ➤Drug substance met all predefined acceptance criteria for assessed quality attributes
- ➤Drug product now supplies Valion’s ongoing AFRRI study
- ➤Production scale increased fourfold from January’s 50-liter run
- ➤Valion plans future CGMP manufacturing while evaluating strategic alternatives for Velocity Bioworks
Expert Statements
Dean Zikria, Interim Chief Executive Officer of Valion Bio
“This run increased our production scale fourfold while also improving productivity. The resulting drug substance met all of our acceptance criteria, with the process yielding more drug substance per liter of fermentation volume,”
Dean Zikria, Interim Chief Executive Officer of Valion Bio
“The material is now supporting our ongoing study with AFRRI. We’re reporting these results as part of our commitment to keeping shareholders informed of progress on our lead program.”
SAN ANTONIO, TX / ACCESS Newswire / November 17, 2026 / Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation, today reported that its wholly owned subsidiary, Velocity Bioworks, completed a 200-liter non-GMP production run of Entolimod at its San Antonio, Texas facility. The run, conducted from May through June 2026, achieved approximately 27% higher productivity compared with historical manufacturing data, and the resulting drug substance met all predefined acceptance criteria for the quality attributes assessed.
Drug product from the run was filled in June and is supplying the Company's ongoing Entolimod study, a study fully funded by the National Institute of Allergy and Infectious Diseases ("NIAID")/Radiation and Nuclear Countermeasures Program (RNCP) under an Interagency Agreement with the Uniformed Services University ("USU")/Armed Forces Radiobiology Research Institute ("AFRRI").
Get started
Create a free account to read the full story.
